The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Impaired Balance of Mitochondrial Fission and Fusion in Alzheimer's Disease
Open accessAbstract
Mitochondrial dysfunction is a prominent feature of Alzheimer's disease (AD) neurons. In this study, we explored the involvement of an abnormal mitochondrial dynamics by investigating the changes in the expression of mitochondrial fission and fusion proteins in AD brain and the potential cause and consequence of these changes in neuronal cells. We found that mitochondria were redistributed away from axons in the pyramidal neurons of AD brain. Immunoblot analysis revealed that levels of DLP1 (also referred to as Drp1), OPA1, Mfn1, and Mfn2 were significantly reduced whereas levels of Fis1 were significantly increased in AD. Despite their differential effects on mitochondrial morphology, manipulations of these mitochondrial fission and fusion proteins in neuronal cells to mimic their expressional changes in AD caused a similar abnormal mitochondrial distribution pattern, such that mitochondrial density was reduced in the cell periphery of M17 cells or neuronal process of primary neurons and correlated with reduced spine density in the neurite. Interestingly, oligomeric amyloid-beta-derived diffusible ligands (ADDLs) caused mitochondrial fragmentation and reduced mitochondrial density in neuronal processes. More importantly, ADDL-induced synaptic change (i.e., loss of dendritic spine and postsynaptic density protein 95 puncta) correlated with abnormal mitochondrial distribution. DLP1 overexpression, likely through repopulation of neuronal processes with mitochondria, prevented ADDL-induced synaptic loss, suggesting that abnormal mitochondrial dynamics plays an important role in ADDL-induced synaptic abnormalities. Based on these findings, we suggest that an altered balance in mitochondrial fission and fusion is likely an important mechanism leading to mitochondrial and neuronal dysfunction in AD brain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Increased accumulation of APP and its processed peptides in the mitochondria of AD neurons and their effects on mitochondrial dynamics and mitophagy have been documented (21–24).”
From Alzheimer's Disease–Associated Amyloid-β Precursor Protein Prevents Aging Stress–Induced Mitophagy and Fumarate Depletion to Improve Antitumor Immunity (2025) · cites this paper as [24]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Mitochondrial fission-fusion dynamics through alterations of Drp1, Parkin, and Pink1 functions (23,24), which play essential roles in mitophagy induction and mitochondrial quality control during healthy brain aging, are disrupted in various neurodegenerative diseases, including Parkinson’s disease (PD) and AD (25).”
From Alzheimer's Disease–Associated Amyloid-β Precursor Protein Prevents Aging Stress–Induced Mitophagy and Fumarate Depletion to Improve Antitumor Immunity (2025) · cites this paper as [24]
In the citing paper
“Aβ accumulates in mitochondria in AD brain, which is accompanied by altered mitochondrial structure, decreased mitochondrial respiratory function and ATP production, impaired mitochondrial dynamics, and elevated mitochondria-associated oxidative stress.”
From Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease (2020) · cites this paper as [97]
In the citing paper
“Mitochondrial Aβ levels correlate with abnormalities in mitochondrial structure and function.”
From Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease (2020) · cites this paper as [97]
In the citing paper
“Aβ peptides can induce ROS production from mitochondria, leading to release of cytochrome c and apoptosis-inducing factor, thereby driving mitochondrial dysfunction, cell apoptosis and neuronal loss [97, 100].”
From Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease (2020) · cites this paper as [97]
In the citing paper
“Soluble Aβ oligomers disrupted the balance between mitochondrial fission and fusion, leading to significant mitochondrial dysfunction.197,198”
From Amyloid β-based therapy for Alzheimer’s disease: Challenges, successes and future (2023) · cites this paper as [197]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Diffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins
Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506
Fission and selective fusion govern mitochondrial segregation and elimination by autophagy
Twig, G., Elorza, A., Molina, A. J. A., Mohamed, H., Wikstrom, J. D., Walzer, G., Stiles, L., Haigh, S. E., Katz, S., Las, G., et al. (2008) · The EMBO Journal · doi:10.1038/sj.emboj.7601963 · Cited by 3,082
Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity
DeKosky, S. T., & Scheff, S. W. (1990) · Annals of Neurology · doi:10.1002/ana.410270502 · Cited by 2,376
Dynamin-related Protein Drp1 Is Required for Mitochondrial Division in Mammalian Cells
Smirnova, E., Griparić, L., Shurland, D., & van der Bliek, A. M. (2001) · Molecular Biology of the Cell · doi:10.1091/mbc.12.8.2245 · Cited by 1,938
Mucke, L., Masliah, E., Yu, G.-Q., Mallory, M., Rockenstein, E. M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K., & McConlogue, L. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04050.2000 · Cited by 1,856
Natural oligomers of the amyloid-β protein specifically disrupt cognitive function
Cleary, J. P., Walsh, D. M., Hofmeister, J. J., Shankar, G. M., Kuskowski, M. A., Selkoe, D. J., & Ashe, K. H. (2004) · Nature Neuroscience · doi:10.1038/nn1372 · Cited by 1,722
APP Processing and Synaptic Function
Kamenetz, F., Tomita, T., Hsieh, H., Seabrook, G., Borchelt, D., Iwatsubo, T., Sisodia, S., & Malinow, R. (2003) · Neuron · doi:10.1016/s0896-6273(03)00124-7 · Cited by 1,644
The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses
Li, Z., Okamoto, K.-I., Hayashi, Y., & Sheng, M. (2004) · Cell · doi:10.1016/j.cell.2004.11.003 · Cited by 1,498
Cited by
Sorted by citations
Items 501–600 of 1,001
Wang, W., Zhao, F., Lu, Y., Siedlak, S. L., Fujioka, H., Feng, H., Perry, G. L., & Zhu, X. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01552-7 · Cited by 52
Self-citationMitophagy and neurodegeneration
Wager, K., & Russell, C. (2013) · Autophagy · doi:10.4161/auto.25082 · Cited by 51
Role of PGC-1α in Mitochondrial Quality Control in Neurodegenerative Diseases
Zhang, Q., Lei, Y.-H., Zhou, J.-P., Hou, Y.-Y., Wan, Z., Wang, H., & Meng, H. (2019) · Neurochemical Research · doi:10.1007/s11064-019-02858-6 · Cited by 53
Novel insights into RIPK1 as a promising target for future Alzheimer’s disease treatment
Li, S., Qu, L., Wang, X., & Kong, L. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107979 · Cited by 51
Self-citationPromising use of metformin in treating neurological disorders: biomarker-guided therapies
Loan, A., Syal, C., Lui, M., He, L., & Wang, J. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.385286 · Cited by 50
Bax Interacting Factor-1 Promotes Survival and Mitochondrial Elongation in Neurons
Wang, D. B., Uo, T., Kinoshita, C., Sopher, B. L., Lee, R. J., Murphy, S. P., Kinoshita, Y., Garden, G. A., Wang, H., & Morrison, R. S. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.4074-13.2014 · Cited by 49
Swerdlow, R. H. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12394 · Cited by 51
Zhang, R., Zhou, H., Jiang, L., Mao, Y., Cui, X., Xie, B., Cui, D., Wang, H., Zhang, Q., & Xu, S. (2016) · Brain Research · doi:10.1016/j.brainres.2016.09.047 · Cited by 49
Filippi, B., Abraham, M. A., Silva, P. N., Rasti, M., LaPierre, M. P., Bauer, P. V., Rocheleau, J. V., & Lam, T. K. T. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.02.035 · Cited by 49
Near infrared light decreases synaptic vulnerability to amyloid beta oligomers
Comerota, M. M., Krishnan, B., & Taglialatela, G. (2017) · Scientific Reports · doi:10.1038/s41598-017-15357-x · Cited by 49
Nie, T., Tao, K., Zhu, L., Huang, L. H., Hu, S., Yang, R., Xu, P., Mao, Z., & Yang, Q. (2020) · Autophagy · doi:10.1080/15548627.2020.1848128 · Cited by 51
Mitochondrial dynamics in aging and disease
Bereiter-Hahn, J. (2014) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-394625-6.00004-0 · Cited by 48
Balancing life and death: BCL‐2 family members at diverse ER–mitochondrial contact sites
Means, R. E., & Katz, S. G. (2021) · FEBS Journal · doi:10.1111/febs.16241 · Cited by 50
Lai, C., Chen, Z., Ding, Y., Qian, C., Su, S., Liu, H., Ni, R., & Tang, Z. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.782434 · Cited by 47
Mitochondrial Perturbation in Alzheimer's Disease and Diabetes
Akhter, F., Chen, D., Yan, S. F., & Yan, S. S. (2017) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2016.12.019 · Cited by 48
Presenilin 2-Dependent Maintenance of Mitochondrial Oxidative Capacity and Morphology
Contino, S., Porporato, P. E., Bird, M., Marinangeli, C., Opsomer, R., Sonveaux, P., Bontemps, F., Dewachter, I., Octave, J., Bertrand, L., et al. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00796 · Cited by 48
Zafeer, M. F., Firdaus, F., Anis, E., & Hossain, M. S. (2019) · NeuroToxicology · doi:10.1016/j.neuro.2019.04.006 · Cited by 48
Acylated Ghrelin as a Multi-Targeted Therapy for Alzheimer's and Parkinson's Disease
Reich, N., & Hölscher, C. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.614828 · Cited by 48
The relevance of mitochondrial morphology for human disease
Navaratnarajah, T., Anand, R., Reichert, A. S., & Distelmaier, F. (2021) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2021.105951 · Cited by 49
Pinto, M., Pickrell, A. M., Fukui, H., & Moraes, C. T. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.04.014 · Cited by 47
Hampel, H. J., Lista, S., Néri, C., & Vergallo, A. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2019.101662 · Cited by 47
The role of mitochondrial defects and oxidative stress in Alzheimer’s disease
Islam, B. U., Jabir, N. R., & Tabrez, S. S. M. (2019) · Journal of drug targeting · doi:10.1080/1061186x.2019.1584808 · Cited by 48
Panchal, K., & Tiwari, A. K. (2020) · Mitochondrion · doi:10.1016/j.mito.2020.10.005 · Cited by 49
Sarkar, S., Jun, S., & Simpkins, J. W. (2015) · Brain Research · doi:10.1016/j.brainres.2015.04.059 · Cited by 47
Park, J., Won, J., Seo, J., Yeo, H.-G., Kim, K., Kim, Y. G., Jeon, C., Kam, M. K., Kim, Y., Huh, J., et al. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00235 · Cited by 45
New Insights into Mitochondria in Health and Diseases
Li, Y., Zhang, H., Yu, C., Dong, X., Yang, F., Wang, M., Wen, Z., Su, M., Li, B., & Yang, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25189975 · Cited by 48
Zhang, Y., Liu, S., Cao, D., Zhao, M., Lu, H., & Wang, P. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.119285 · Cited by 48
Activation of the Mitochondrial Unfolded Protein Response: A New Therapeutic Target?
Suarez-Rivero, J. M., Pastor‐Maldonado, C. J., Povea-Cabello, S., Álvarez-Córdoba, M., Villalón-García, I., Talaverón-Rey, M., Suárez-Carrillo, A., Munuera-Cabeza, M., Reche-López, D., Cilleros-Holgado, P., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10071611 · Cited by 47
Splitting up the powerhouse: structural insights into the mechanism of mitochondrial fission
Richter, V., Singh, A. P., Kvansakul, M., Ryan, M. T., & Osellame, L. D. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1950-y · Cited by 48
Litwiniuk, A., Baranowska-Bik, A., Domańska, A., Kalisz, M., & Bik, W. (2021) · Pharmaceuticals · doi:10.3390/ph14121221 · Cited by 46
Mechanisms of Mitochondrial Malfunction in Alzheimer’s Disease: New Therapeutic Hope
Nabi, S. U., Khan, A., Siddiqui, E. M., Rehman, M. U., Alshahrani, S., Arafah, A. M., Mehan, S., Alsaffar, R. M., Alexiou, A. T., & Shen, B. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/4759963 · Cited by 51
Kshirsagar, S., Alvir, R. V., Pradeepkiran, J. A., Hindle, A., Vijayan, M., Ramasubramaniam, B., Kumar, S., Reddy, A. P., & Reddy, P. H. (2022) · Cells · doi:10.3390/cells11172660 · Cited by 47
RetractedRole of Mitochondrial Dysfunctions in Neurodegenerative Disorders: Advances in Mitochondrial Biology
Kathiresan, D. S., Balasubramani, R., Marudhachalam, K., Jaiswal, P., Ramesh, N., Suruthi, G. S., Moorthi, P. V., & Vijayan, M. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04469-x · Cited by 49
Strategic Role for Mitochondria in Alzheimer's Disease and Cancer
Hedskog, L., Zhang, S., & Ankarcrona, M. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4259 · Cited by 45
Mitochondrial dysfunction and Down's syndrome: Is there a role for coenzyme Q10?
Tiano, L., & Busciglio, J. A. (2011) · BioFactors · doi:10.1002/biof.184 · Cited by 45
Brunetti, D., Bottani, E., Segala, A., Marchet, S., Rossi, F., Orlando, F., Malavolta, M., Carruba, M. O., Lamperti, C., Provinciali, M., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01171 · Cited by 43
Grieco, J. P., Allen, M. E., Perry, J. B., Wang, Y., Song, Y., Rohani, A., Compton, S. L. E., Smyth, J. W., Swami, N. S., Brown, D. A., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.600113 · Cited by 42
Regulation of neuronal bioenergetics as a therapeutic strategy in neurodegenerative diseases
Onyango, I. G., Bennett, J. P., & Stokin, G. B. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.303007 · Cited by 45
Hu, D., Liu, Z., & Qi, X. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.746873 · Cited by 44
Mitochondrial medicine and the neurodegenerative mitochondriopathies
Swerdlow, R. H. (2009) · Pharmaceuticals · doi:10.3390/ph2030150 · Cited by 43
N1-methylation of adenosine (m1A) in ND5 mRNA leads to complex I dysfunction in Alzheimer’s disease
Jörg, M., Plehn, J. E., Kristen, M., Lander, M., Walz, L., Lietz, C., Wijns, J., Pichot, F., Rojas-Charry, L., Martin, K., et al. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02421-y · Cited by 43
Sridharan, P. S., Koh, Y., Miller, E., Hu, D., Chakraborty, S., Tripathi, S. J., Kee, T. R., Chaubey, K., Vázquez‐Rosa, E., Barker, S., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101715 · Cited by 44
SanMartín, C. D., Paula-Lima, A. C., GarcÃa, A., Veloso, P., Härtel, S., NÃoñez, M. T., & Hidalgo, C. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00013 · Cited by 43
Time representation of mitochondrial morphology and function after acute spinal cord injury
Lv, G., Jia, Z., Li, G., Zhang, Z.-Y., Li, H.-T., Wang, J.-Q., & Fan, Z. (2016) · Neural Regeneration Research · doi:10.4103/1673-5374.175061 · Cited by 44
Effects of treadmill exercise on mitochondrial fusion and fission in the hippocampus of APP/PS1 mice
Yan, Q.-W., Zhao, N., Xia, J., Li, B., & Yin, L. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.02.030 · Cited by 44
Karri, V., Schuhmacher, M., & Kumar, V. (2020) · Food and Chemical Toxicology · doi:10.1016/j.fct.2020.111257 · Cited by 46
Coconut Oil Attenuates the Effects of Amyloid-β on Cortical Neurons in vitro
Nafar, F., & Mearow, K. M. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-131436 · Cited by 44
DJ-1 promotes the proteasomal degradation of Fis1: implications of DJ-1 in neuronal protection
Zhang, Q., Wu, J., Wu, R., Ma, J., Du, G., Jiao, R., Tian, Y., Zheng, Z., & Yuan, Z. (2012) · Biochemical Journal · doi:10.1042/bj20120598 · Cited by 44
Paul, S. C., Saha, D., & Binukumar, B. K. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02365-2 · Cited by 43
The role of mitochondrial disturbances in Alzheimer, Parkinson and Huntington diseases
Carvalho, C., Correia, S. C., Cardoso, S., Plácido, A. I., Candeias, E., Duarte, A. I., & Moreira, P. I. (2015) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2015.1058160 · Cited by 45
Membrane fusion and vesicular transformation induced by Alzheimer's amyloid beta
Vestergaard, M. C. M., Morita, M., Hamada, T., & Takagi, M. (2013) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2013.01.015 · Cited by 43
Wang, W., Ma, X., Zhou, L., Liu, J., & Zhu, X. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw430 · Cited by 45
Self-citationYu, X., Jia, L., Yu, W., & Du, H. (2019) · Brain Research · doi:10.1016/j.brainres.2019.01.018 · Cited by 43
Zhang, C., Wang, J., Zhu, J., Chen, Y., & Han, X. (2019) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2019.134702 · Cited by 44
Camberos-Luna, L., & Massieu, L. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.104614 · Cited by 44
Mahley, R. W. (2023) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2023.102684 · Cited by 43
Reich, N., & Hölscher, C. (2024) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2024.101122 · Cited by 43
Hypobaric Hypoxia Imbalances Mitochondrial Dynamics in Rat Brain Hippocampus
Jain, K., Prasad, D. N., Singh, S. B., & Kohli, E. (2015) · Neurology Research International · doi:10.1155/2015/742059 · Cited by 42
RetractedDimebon Ameliorates Amyloid-β Induced Impairments of Mitochondrial Form and Function
Eckert, S. H., Eckmann, J., Renner, K., Eckert, G. P., Leuner, K., & Muller, W. E. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120310 · Cited by 42
Novel therapeutics for Alzheimer's disease: an update.
Bonda, D., Lee, H. P., Lee, H., Friedlich, A. L., Perry, G. L., Zhu, X., & Smith, M. A. (2010) · PubMed · Cited by 41
Self-citationMitochondrial dysfunction in cellular senescence: a bridge to neurodegenerative disease
Hruby, A. J., & Higuchi‐Sanabria, R. (2025) · npj Aging · doi:10.1038/s41514-025-00291-4 · Cited by 52
Chiu, M., & Fan, L. (2014) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s45143 · Cited by 41
Anesthesia-Induced Developmental Neurodegeneration: The Role of Neuronal Organelles
Jevtović‐Todorović, V., Boscolo, A., Sanchez, V., & Lunardi, N. (2012) · Frontiers in Neurology · doi:10.3389/fneur.2012.00141 · Cited by 40
Lennon, F. E., Cianci, G. C., Kanteti, R., Riehm, J., Arif, Q., Poroyko, V. A., Lupovitch, E., Vigneswaran, W. T., Husain, A. N., Chen, P., et al. (2016) · Scientific Reports · doi:10.1038/srep24578 · Cited by 41
Mitochondrial dysfunction in neurodegenerative diseases: A focus on iPSC-derived neuronal models
Trombetta-Lima, M., Sabogal-Guáqueta, A. M., & Dolga, A. M. (2021) · Cell Calcium · doi:10.1016/j.ceca.2021.102362 · Cited by 42
Bertan, F., Wischhof, L., Sosulina, L., Mittag, M., Dalügge, D., Fornarelli, A., Gardoni, F., Marcello, E. E., Luca, M. D., Fuhrmann, M., et al. (2020) · Cell Death and Differentiation · doi:10.1038/s41418-020-0584-2 · Cited by 42
Adlimoghaddam, A., Odero, G. G., Glazner, G., Turner, R. S., & Albensi, B. C. (2021) · Aging and disease · doi:10.14336/ad.2020.0910 · Cited by 38
Vijayan, M., Alvir, R. V., Alvir, R. V., Bunquin, L. E., Pradeepkiran, J. A., & Reddy, P. H. (2022) · Aging Cell · doi:10.1111/acel.13663 · Cited by 40
Afsar, A., Castro, M. D. C. C., Soladogun, A. S., & Li, Z. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087258 · Cited by 45
Cross Talk of Proteostasis and Mitostasis in Cellular Homeodynamics, Ageing, and Disease
Gumeni, S., & Trougakos, I. P. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/4587691 · Cited by 43
Mitochondrial Dysfunction in Alzheimer’s Disease and Progress in Mitochondria-Targeted Therapeutics
Flannery, P. J., & Trushina, E. V. (2019) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-019-00179-0 · Cited by 41
Mechanistic and therapeutic role of Drp1 in the pathogenesis of Alzheimer's disease
Bera, A., Lavanya, G., Reshmi, R., Dev, K., & Kumar, R. K. (2022) · European Journal of Neuroscience · doi:10.1111/ejn.15611 · Cited by 43
Zhu, Y., Li, Y., Zhang, Q., Song, Y., Wang, L., & Zhu, Z. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.798917 · Cited by 40
Qu, J. T., Nakamura, T., Holland, E. A., McKercher, S. R., & Lipton, S. A. (2012) · Prion · doi:10.4161/pri.21250 · Cited by 40
Enhanced defense against mitochondrial hydrogen peroxide attenuates age-associated cognition decline
Chen, L., Na, R., & Ran, Q. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.05.007 · Cited by 39
Amyloid precursor protein‐mediated mitochondrial regulation and Alzheimer's disease
Lopez Sanchez, M. I. G., van Wijngaarden, P., & Trounce, I. A. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14554 · Cited by 45
Therapeutic Potential of Targeting Mitochondria for Alzheimer’s Disease Treatment
Atlante, A., Amadoro, G., Latina, V., & Valenti, D. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11226742 · Cited by 40
Mitochondria: Joining forces to thwart cell death
Jahani‐Asl, A., Germain, M., & Slack, R. S. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.09.006 · Cited by 39
Axonal Transport and Mitochondrial Dysfunction in Alzheimer's Disease
Riemer, J., & Kins, S. (2012) · Neurodegenerative Diseases · doi:10.1159/000342020 · Cited by 39
Hirano, M., Yoshii, K., Sakai, M., Hasebe, R., Ichii, O., & Kariwa, H. (2014) · Journal of General Virology · doi:10.1099/vir.0.061432-0 · Cited by 40
Chen, Y., Han, S., Huang, X., Ni, J., & He, X. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17020163 · Cited by 39
Chang, J., Wu, S., Hoel, F., Cheng, Y.-S., Liu, K.-H., Hsieh, M., Hoel, A., Tronstad, K. J., Yan, K.-C., Hsieh, C., et al. (2016) · Scientific Reports · doi:10.1038/srep30436 · Cited by 39
Li, C., Wang, D., Wu, W., Yang, W., Shah, S. Z. A., Zhao, Y., Duan, Y., Wang, L., Zhou, X., Zhao, D., et al. (2017) · Aging Cell · doi:10.1111/acel.12693 · Cited by 39
Ghrelin mediated neuroprotection - A possible therapy for Parkinson's disease?
Morgan, A. H., Rees, D. J., Andrews, Z. B., & Davies, J. S. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.12.027 · Cited by 40
Phenylpropanoids and Alzheimer's disease: A potential therapeutic platform
Kolaj, I., Liyanage, S. I., & Weaver, D. F. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2018.08.001 · Cited by 39
Mitochondrial fragmentation and network architecture in degenerative diseases
Shah, S. I., Paine, J. G., Perez, C., & Ullah, G. (2019) · PLoS ONE · doi:10.1371/journal.pone.0223014 · Cited by 40
Du, X., Shi, Q., Zhao, Y., Xie, Y., Li, X., Liu, Q., Iqbal, J., Zhang, H., Liu, X., & Shen, L. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00549 · Cited by 38
Self-citationThe “mitochondrial stress responses”: the “Dr. Jekyll and Mr. Hyde” of neuronal disorders
Rimessi, A., Patergnani, S., Morciano, G., Carinci, M., Leo, S., & Pinton, P. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.339473 · Cited by 41
Zhang, Y., Han, L., Sakah, K., Wu, Z.-Z., Liu, L., Agyemang, K., Gao, X., & Wang, T. (2013) · Molecules · doi:10.3390/molecules180910352 · Cited by 38
Bandaru, L. J. M., Ayyalasomayajula, N., Murumulla, L., & Challa, S. (2022) · BioMetals · doi:10.1007/s10534-021-00360-7 · Cited by 39
CNS Redox Homeostasis and Dysfunction in Neurodegenerative Diseases
Goldsteins, G., Hakosalo, V., Jaronen, M., Keuters, M. H., Lehtonen, Š., & Koıstınaho, J. (2022) · Antioxidants · doi:10.3390/antiox11020405 · Cited by 42
Mitochondrial Dynamics and Insulin Secretion
Kabra, U. D., & Jastroch, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241813782 · Cited by 40
Evolving therapeutic interventions for the management and treatment of Alzheimer’s disease
Ahmad, F., Karan, A., Sharma, R., Sharma, N. S., Sundar, V., Jayaraj, R. L., Mukherjee, S., & DeCoster, M. A. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102229 · Cited by 40
Ali, J., Choe, K., Park, J. S., Park, H. Y., Kang, H., Park, T. J., & Kim, M.-O. (2024) · Antioxidants · doi:10.3390/antiox13070862 · Cited by 42
Engmann, O., Hortobágyi, T., Thompson, A., Guadagno, J., Troakes, C., Soriano, S., Al‐Sarraj, S., Kim, Y. D., & Giese, K.-P. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.04.011 · Cited by 38
Arefin, A. S., Mathieson, L., Johnstone, D. M., Berretta, R. E., & Moscato, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045535 · Cited by 39
Hoque, S. A. M., Kawai, T., Zhu, Z., & Shimada, M. (2018) · Journal of the Endocrine Society · doi:10.1210/js.2018-00329 · Cited by 38
Gao, J., Wang, L., Gao, C., Arakawa, H., Perry, G. L., & Wang, X. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.165580 · Cited by 38
Self-citationFinelli, M. J. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00254 · Cited by 38
Mitochondrial dynamics and its impact on human health and diseases: inside the DRP1 blackbox
Banerjee, R., Mukherjee, A., & Nagotu, S. (2021) · Journal of Molecular Medicine · doi:10.1007/s00109-021-02150-7 · Cited by 40
Metadata
- Authors
- Wang, X., Su, B., Lee, H.-G., Li, X., Perry, G., Smith, M. A., & Zhu, X.
- Affiliations
- Case Western Reserve University (US)
- The University of Texas at San Antonio (US)
- Venue
- Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2009-07-15
- Volume
- 29
- Issue
- 28
- Pages
- 9090-9103
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC2735241
- OpenAlex
- W2089141103
- Cited by
- 1,224
- References
- 50
- Citations by year
- 2026: 49 · 2025: 82 · 2024: 71 · 2023: 92 · 2022: 77 · 2021: 102 · 2020: 83 · 2019: 71 · 2018: 60 · 2017: 75 · 2016: 67 · 2015: 59 · 2014: 57 · 2013: 58 · 2012: 84
- FWCI
- 29.56
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Neuroscience (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Alzheimer's Association (AG031852, IIRG-07-60196)
- National Institutes of Health (IIRG-07-60196)
- National Institute on Aging (AG 031852, R01AG031852)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Keywords
- Alzheimer's disease, mitochondrial dynamics, mitochondrial fission, mitochondrial fusion, Drp1, OPA1, Mfn1, mitofusin 2, Fis1, mitochondrial distribution, axons, pyramidal neurons, synaptic loss, dendritic spines, PSD-95, mitochondrial dysfunction
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Animals, Antibodies, Monoclonal, Biotin, Cells, Cultured, Embryo, Mammalian, Gene Expression Regulation, Hippocampus, Humans, Membrane Proteins, Microtubule-Associated Proteins, Middle Aged, Mitochondria, Mutation, Neuroblastoma, Neurons, Postmortem Changes, Time Factors, Transfection, Amyloid beta-Peptides, Microscopy, Immunoelectron, Reactive Oxygen Species, GTP Phosphohydrolases, Mitochondrial Proteins, Membrane Transport Proteins, Mitochondrial Membrane Transport Proteins, Dynamins, Green Fluorescent Proteins, Rats, Cyclooxygenase 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
